Association between multiple sclerosis disease severity and adherence to disease-modifying therapies

BACKGROUND: For multiple sclerosis (MS) patients taking disease-modifying therapies (DMTs), adherence to treatment is a key component of achieving beneficial outcomes, such as delayed disease progression and the reduction and prevention of symptoms and relapses. OBJECTIVES: The aim of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Burkhard, Adam, Toliver, Joshua, Rascati, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391086/
https://www.ncbi.nlm.nih.gov/pubmed/34185555
http://dx.doi.org/10.18553/jmcp.2021.27.7.915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391086/
https://www.ncbi.nlm.nih.gov/pubmed/34185555
http://dx.doi.org/10.18553/jmcp.2021.27.7.915

Ejemplares similares